X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse JUBILANT LIFE SCIENCES with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 JUBILANT LIFE SCIENCES   TEVA PHARMA
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-18
TEVA PHARMA
Dec-13
JUBILANT LIFE SCIENCES/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0392,866-   
Low Rs6002,490-   
Sales per share (Unadj.) Rs482.61,644.8-  
Earnings per share (Unadj.) Rs40.7102.7-  
Cash flow per share (Unadj.) Rs67.4235.7-  
Dividends per share (Unadj.) Rs3.0089.94-  
Dividend yield (eoy) %0.43.4 10.9%  
Book value per share (Unadj.) Rs262.31,827.0-  
Shares outstanding (eoy) m155.79848.00-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.71.6 104.3%   
Avg P/E ratio x20.126.1 77.2%  
P/CF ratio (eoy) x12.211.4 107.1%  
Price / Book Value ratio x3.11.5 213.2%  
Dividend payout %7.487.5 8.4%   
Avg Mkt Cap Rs m127,6702,270,724 5.6%   
No. of employees `0002.444.9 5.4%   
Total wages/salary Rs m15,5590-   
Avg. sales/employee Rs Th30,861.431,032.6 99.4%   
Avg. wages/employee Rs Th6,387.00-   
Avg. net profit/employee Rs Th2,604.41,938.6 134.3%   
INCOME DATA
Net Sales Rs m75,1781,394,759 5.4%  
Other income Rs m4000-   
Total revenues Rs m75,5791,394,759 5.4%   
Gross profit Rs m15,184381,956 4.0%  
Depreciation Rs m4,151112,740 3.7%   
Interest Rs m2,84327,395 10.4%   
Profit before tax Rs m8,591241,821 3.6%   
Minority Interest Rs m01,099 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-158,742 0.0%   
Tax Rs m2,247-2,952 -76.1%   
Profit after tax Rs m6,34487,130 7.3%  
Gross profit margin %20.227.4 73.8%  
Effective tax rate %26.2-1.2 -2,142.0%   
Net profit margin %8.46.2 135.1%  
BALANCE SHEET DATA
Current assets Rs m31,898942,015 3.4%   
Current liabilities Rs m20,047821,517 2.4%   
Net working cap to sales %15.88.6 182.5%  
Current ratio x1.61.1 138.8%  
Inventory Days Days6891 74.4%  
Debtors Days Days5596 57.2%  
Net fixed assets Rs m60,715455,559 13.3%   
Share capital Rs m1563,433 4.5%   
"Free" reserves Rs m40,7100-   
Net worth Rs m40,8651,549,313 2.6%   
Long term debt Rs m30,478713,171 4.3%   
Total assets Rs m96,1763,187,472 3.0%  
Interest coverage x4.09.8 40.9%   
Debt to equity ratio x0.70.5 162.0%  
Sales to assets ratio x0.80.4 178.6%   
Return on assets %9.63.6 265.9%  
Return on equity %15.55.6 276.1%  
Return on capital %16.04.9 325.0%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m2,3580-   
CASH FLOW
From Operations Rs m13,032222,252 5.9%  
From Investments Rs m-6,177-78,753 7.8%  
From Financial Activity Rs m-9,011-266,607 3.4%  
Net Cashflow Rs m-2,123-123,107 1.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 68.66 Rs / USD

Compare JUBILANT LIFE SCIENCES With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare JUBILANT LIFE SCIENCES With: PFIZER  IPCA LABS  ELDER PHARMA  NATCO PHARMA  STERLING BIOTECH  



Today's Market

Sensex Ends 160 Points Higher; IT and Healthcare Stocks Witness Buying(Closing)

Indian share markets traded on a positive note most of the day and ended higher. Gains were largely seen in the IT sector and healthcare sector, while capital goods stocks witnessed selling pressure.

Related Views On News

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY19); Net Profit Down 166.0% (Quarterly Result Update)

May 21, 2019 | Updated on May 21, 2019

For the quarter ended March 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 1 bn (down 166.0% YoY). Sales on the other hand came in at Rs 24 bn (up 5.9% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY19); Net Profit Up 25.7% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 3 bn (up 25.7% YoY). Sales on the other hand came in at Rs 24 bn (up 15.0% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

More Views on News

Most Popular

I Believe this is the Best Stock to Buy Today (Profit Hunter)

Jul 3, 2019

The languishing small cap space is currently offering a very fertile market to pick up bargains at very attractive prices. This is a perfect opportunity ripe for the picking.

This Smallcap Stock could be the next Page Industries (Profit Hunter)

Jul 2, 2019

The smallcap rebound is taking longer to play out...and that's good news as it gives you more of action time and opportunities to invest in.

The Indian Rating Agency Cleanup Has Begun and this Cheap Stock Could be the Best Bet (The 5 Minute Wrapup)

Jul 2, 2019

The last time this big rating agency was as cheap and out-of-favour as it is today, the stock had corrected by 40% in six months.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On... (The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors (The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Jul 15, 2019 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 5-YR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS